Skip to main content

Table 5 Comparison of P-cadherin expression in different breast cancer subtypes

From: Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin

  IBC Non-IBC p-value
  n(%) n(%)  
Basal cases (ER-,ERBB2-) 18/19(95%) 35/51(69%) 0.05
ERBB2-overexpressing cases 9/13(69%) 32/47(68%) NS
Luminal cases (ER+, PR+) 14/17(82%) 84/197(43%) <0.01